What is the Purpose of this Study?
The primary objective of this study is to generate early feasibility data for the MonarQ TTVR System (including a transjugular or transfemoral delivery system) for the treatment of adult patients with severe or greater, symptomatic tricuspid regurgitation in patients who are considered high risk for surgical intervention based on Heart Team assessment
Eligibility
- * Anatomically suitable for the MonarQ TTVR System
- * Symptomatic, tricuspid regurgitation (TR) that is severe or greater
- * Adequately treated for heart failure based upon medical standards
- * Hemodynamically stable
Where can I participate?
Beverly
More about this Clinical Trial
What is the full name of this clinical trial?
A Clinical Study of the inQB8 MonarQ Transcatheter Tricuspid Valve Replacement System